InspireMD (NYSE:NSPR) and Titan Medical (NASDAQ:TMDI) Head-To-Head Review

InspireMD (NYSE:NSPRGet Rating) and Titan Medical (NASDAQ:TMDIGet Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Earnings & Valuation

This table compares InspireMD and Titan Medical’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
InspireMD $4.49 million 2.06 -$14.92 million ($2.27) -0.49
Titan Medical $20.09 million 2.28 -$14.86 million ($0.19) -2.16

Titan Medical has higher revenue and earnings than InspireMD. Titan Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

1.7% of InspireMD shares are held by institutional investors. Comparatively, 3.3% of Titan Medical shares are held by institutional investors. 3.8% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for InspireMD and Titan Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InspireMD 0 0 0 0 N/A
Titan Medical 0 1 0 0 2.00

Volatility and Risk

InspireMD has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500.


This table compares InspireMD and Titan Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
InspireMD -321.14% -64.03% -52.30%
Titan Medical N/A -167.03% -112.15%


Titan Medical beats InspireMD on 7 of the 11 factors compared between the two stocks.

About InspireMD

(Get Rating)

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

About Titan Medical

(Get Rating)

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with's FREE daily email newsletter.